Table 1. Clinical baseline characteristics of the population studied.
| Serum control group (n = 20) Mean ± SD |
Patients who underwent carotid endarterectomy (n = 20) Mean ± SD |
p-value | |
|---|---|---|---|
| Age (years) | 69.43 ± 3.21 | 66.88 ± 4.99 | 0.292 |
| Weight (kg) | 74.15 ± 8.64 | 74.71 ± 12.78 | 0.872 |
| BMI (kg/m2) | 25.95 ± 3.13 | 27.18 ± 3.68 | 0.266 |
| Glucose (mg/dl) | 87.31 ± 18.31 | 106.58 ± 26.08 | 0.018 |
| HbA1c (%) | 5.26 ± 0.38 | 6.11 ± 1.00 | 0.003 |
| Insulin (mUI/L) | 6.94 ± 4.15 | 10.76 ± 10.09 | 0.143 |
| HOMA2-IR | 0.93 ± 0.53 | 1.42 ± 1.26 | 0.139 |
| Triglycerides (mg/dL) | 92.53 ± 38.19 | 123.74 ± 72.45 | 0.112 |
| Cholesterol (mg/dl) | 176.84 ± 42.37 | 115.89 ± 32.19 | <0.001 |
| HDL-C (mg/dL) | 46.80 ± 20.41 | 29.47 ± 5.42 | 0.003 |
| LDL-C (mg/dL) | 111.52 ± 29.36 | 64.23 ± 24.02 | <0.001 |
| DBP (mmHg) | 76.94 ± 9.26 | 73.72 ± 14.82 | 0.439 |
| SBP (mmHg) | 128.94 ± 8.79 | 130.39 ± 10.22 | 0.498 |
| Lipid-lowering therapy (%) | - | 75 | - |
| Antihypertensive therapy (%) | - | 50 | - |
BMI. body mass index; HbA1c. glycosylated haemoglobin; HDL-C. high density lipoprotein; HOMA2-IR. homeostatic model assessment 2-insulin resistance; LDL-C. low density lipoprotein; DBP. diastolic blood pressure; SBP. systolic blood pressure. Data are expressed as mean ± SD. P<0.05 are considered statistically significant. HOMA-2 is calculated using the HOMA Calculator version 2.2.2 (http://www.dtu.ox.ac.uk).